1,355 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Biofire Defense recalled 130 kits of the FilmArray NGDS Warrior Panel on July 10, 2025. The recall is due to an increased risk of internal control failures when testing positive blood cultures. These failures could delay results and require additional diagnostic workups.
Boothwyn Pharmacy recalled 642 vials of Semaglutide injection on July 9, 2025. The recall follows the discovery that the drug is subpotent. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Boothwyn Pharmacy recalled 186 vials of Semaglutide, 2.5 mg/mL injection on July 9, 2025. The product is subpotent and poses a risk to consumers. Healthcare providers and consumers should stop using this product immediately.
Boothwyn Pharmacy recalled 8 vials of Fluorescein 2% Ophthalmic Solution on July 9, 2025. The recall occurred due to the drug being subpotent, posing potential health risks. Consumers should stop using the product immediately and seek guidance from their healthcare provider.
Boothwyn Pharmacy recalled 648 vials of Semaglutide injection on July 9, 2025. The product is subpotent and poses a high hazard risk. Consumers should stop using the product immediately and contact their healthcare provider.
Boston Scientific Neuromodulation recalled 25,260 deep brain stimulation systems on July 8, 2025, due to wire break issues. Users may experience loss of therapy and other serious complications. Patients should stop using the devices immediately and seek further instructions.
Good Neighbor Pharmacy recalled 66,000 alcohol prep pads on July 7, 2025. The product failed to meet isopropyl alcohol concentration standards. Consumers should stop using the product immediately.
CURAD recalled 1,639,996 alcohol prep pads on July 7, 2025. The recall addresses subpotent isopropyl alcohol levels that fall below labeled concentration. Consumers should stop using these products immediately.
Walmart recalled 3.46 million ReliOn Sterile Alcohol Swabs on July 7, 2025. The swabs contain isopropyl alcohol levels below the labeled concentration. Consumers should stop using the product immediately.
Medline Industries recalled approximately 6.67 million alcohol prep pads on July 7, 2025. The recall stems from isopropyl alcohol levels falling below the labeled concentration. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Rite Aid recalled 984,000 first aid alcohol prep pads on July 7, 2025, due to subpotent isopropyl alcohol levels. The affected product may not effectively disinfect, posing health risks to users.
H-E-B recalled 300,000 units of inControl Sterile Alcohol Pads on July 7, 2025. The recall follows reports that isopropyl alcohol levels fall below the labeled concentration. Consumers should stop using the product immediately.
Tandem Diabetes Care recalled 19 t:slim X2 Insulin Pumps on July 3, 2025, due to an app defect. The defect affects devices when set to right-to-left languages, potentially causing incorrect therapy decisions. This may lead to hypoglycemia or hyperglycemia.
North American Rescue recalled 552 Junctional Emergency Treatment Tools on July 1, 2025. The device may have a manufacturing defect that compromises its structural integrity. Healthcare providers should stop using it immediately and follow recall instructions.
bioMerieux recalled 235,269 VITEK 2 Gram-negative AST Test Kits on June 26, 2025. The recall follows potential false resistant results for Colistin with specific bacteria. This may affect patient treatment decisions in multiple countries.
Orthofix U.S. recalled three intervertebral body fusion devices on June 24, 2025. A labeling error states the width as 33 mm instead of the correct 37 mm. Patients and healthcare providers must stop using the device immediately.
Quidel Corporation recalled 22,470 Dipstick Strep A Tests on June 17, 2025, due to potential false positive results. The recall affects tests distributed in multiple U.S. states and internationally. Patients and healthcare providers must stop using the device immediately.
Immunocore Limited recalled 7,572 vials of KIMMTRAK injection on June 10, 2025. The affected lots may not provide the intended therapeutic effect. Consumers and healthcare providers should stop using the product immediately.
SEDECAL SA recalled one Mobile X-ray system on June 10, 2025, due to a lack of water resistance. Improper cleaning can lead to serious hazards. Users must stop using the device immediately and follow the manufacturer’s instructions.
Sedecal recalled nine units of its SM-40HF-Batt Mobile X-ray system on June 10, 2025, due to safety concerns. The equipment is not water-resistant and improper cleaning could lead to dangerous consequences. Patients and healthcare providers must stop using the device immediately.
Sedecal recalled 27 units of its Mobile X-ray system on June 10, 2025. The devices lack water resistance and require strict cleaning per the manual. Improper cleaning could lead to serious issues for users.
SEDECAL SA recalled six units of its mobile X-ray system on June 10, 2025. The equipment is not water-resistant and requires strict cleaning protocols. Improper cleaning could have serious consequences for users.
SEDECAL SA recalled one Mobile X-ray system on June 10, 2025, due to improper cleaning instructions. The device is not water-resistant, posing a potential hazard for users. This recall serves as a reminder to follow all cleaning protocols strictly to avoid consequences.
SEDECAL SA recalled 12 units of its Mobile X-ray system on June 10, 2025, due to water resistance issues. Users must adhere to strict cleaning instructions to avoid equipment damage. The recall affects units distributed in California, Illinois, and New Jersey.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.